|
KCR is an international Contract Research Organization (CRO) providing a full service model for Trial Execution (Phase I-IV), Functional Service Provision (FSP) and Late Phase across a wide range of therapeutic areas. The company operates in 19 countries in Europe as well as the U.S., and employs over 300 professionals. The Head Office is located in Berlin, Germany. The company has a status of Research and Development Center by Polish Government and „Le crédit d'impôt recherche” by French Ministry of Education (Ministère de l'Éducation Nationale). KCR is also certified EN ISO 9001-2008 (Feb 2007). KCR International Conference on Harmonization Good Clinical Practice (ICH GCP) Investigator Site Personnel Training is recognized by (TransCelerate Biopharma Inc. ) (June 2014). == History == KCR was established in 1997 by Marek Kiecana as Kiecana Clinical Research. The company was providing services for clinical monitoring, clinical project management, safety/pharmacovigilance, regulatory affairs and quality assurance. Since its early days KCR forged a path in Central and Eastern Europe (CEE) and developed further to the East and across Western Europe and the U.S. In March 2014 KCR opened new offices in Germany and UK. In April 2014 KCR launched a new service company: (KCR Placement ), which offers recruitment solutions for pharma and biotech in Europe. In 2015 the company Head Office was moved from Warsaw, Poland to Berlin, Germany. ; Key Dates * 1997: Company founded by Marek Kiecana * 2007: Adam Kruszewski appointed President * 2009: KCR opens office in Russia * 2010: KCR establishes its branch in the U.S. * 2013: (Mike Jagielski ) appointed President & CEO * 2014: KCR opens offices in Germany and UK * 2014: KCR launches new company: (KCR Placement ) * 2015: KCR moves the Head Office to Berlin, Germany 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「KCR CRO」の詳細全文を読む スポンサード リンク
|